These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 25451138)

  • 1. Delivery systems for the treatment of degenerated intervertebral discs.
    Blanquer SB; Grijpma DW; Poot AA
    Adv Drug Deliv Rev; 2015 Apr; 84():172-87. PubMed ID: 25451138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advancing the cellular and molecular therapy for intervertebral disc disease.
    Sakai D; Grad S
    Adv Drug Deliv Rev; 2015 Apr; 84():159-71. PubMed ID: 24993611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current trends in biologics delivery to restore intervertebral disc anabolism.
    Fontana G; See E; Pandit A
    Adv Drug Deliv Rev; 2015 Apr; 84():146-58. PubMed ID: 25174310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anabolic effects of Peniel 2000, a peptide that regulates TGF-β1 signaling on intervertebral disc degeneration.
    Kwon YJ; Lee JW; Moon EJ; Chung YG; Kim OS; Kim HJ
    Spine (Phila Pa 1976); 2013 Jan; 38(2):E49-58. PubMed ID: 23124260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-inflammatory Chitosan/Poly-γ-glutamic acid nanoparticles control inflammation while remodeling extracellular matrix in degenerated intervertebral disc.
    Teixeira GQ; Leite Pereira C; Castro F; Ferreira JR; Gomez-Lazaro M; Aguiar P; Barbosa MA; Neidlinger-Wilke C; Goncalves RM
    Acta Biomater; 2016 Sep; 42():168-179. PubMed ID: 27321188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Review of Gene Therapy Delivery Systems for Intervertebral Disc Degeneration.
    Chen S; Luo M; Kou H; Shang G; Ji Y; Liu H
    Curr Pharm Biotechnol; 2020; 21(3):194-205. PubMed ID: 31749423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell death in intervertebral disc degeneration.
    Ding F; Shao ZW; Xiong LM
    Apoptosis; 2013 Jul; 18(7):777-85. PubMed ID: 23512131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis of intervertebral disc degeneration.
    Gopal D; Ho AL; Shah A; Chi JH
    Adv Exp Med Biol; 2012; 760():114-33. PubMed ID: 23281517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic effect of combined growth factors in porcine intervertebral disc degeneration.
    Cho H; Lee S; Park SH; Huang J; Hasty KA; Kim SJ
    Connect Tissue Res; 2013; 54(3):181-6. PubMed ID: 23586390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human bone morphogenetic protein 7 transfected nucleus pulposus cells delay the degeneration of intervertebral disc in dogs.
    Gu T; Shi Z; Wang C; Chen C; Wu J; Wang D; Xu C; Qing H; Dike R
    J Orthop Res; 2017 Jun; 35(6):1311-1322. PubMed ID: 26218641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of human nucleus pulposus cell specific serotypes of adeno-associated virus for gene therapeutic approaches of intervertebral disc disorders.
    Mern DS; Thomé C
    BMC Musculoskelet Disord; 2015 Nov; 16():341. PubMed ID: 26552484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intradiscal delivery of celecoxib-loaded microspheres restores intervertebral disc integrity in a preclinical canine model.
    Tellegen AR; Rudnik-Jansen I; Beukers M; Miranda-Bedate A; Bach FC; de Jong W; Woike N; Mihov G; Thies JC; Meij BP; Creemers LB; Tryfonidou MA
    J Control Release; 2018 Sep; 286():439-450. PubMed ID: 30110616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the extracellular matrix: matricellular proteins regulate cell-extracellular matrix communication within distinct niches of the intervertebral disc.
    Bedore J; Leask A; Séguin CA
    Matrix Biol; 2014 Jul; 37():124-30. PubMed ID: 24874179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lentiviral CRISPR Epigenome Editing of Inflammatory Receptors as a Gene Therapy Strategy for Disc Degeneration.
    Farhang N; Ginley-Hidinger M; Berrett KC; Gertz J; Lawrence B; Bowles RD
    Hum Gene Ther; 2019 Sep; 30(9):1161-1175. PubMed ID: 31140325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Regenerative medicine of the intervertebral disc: from pathophysiology to clinical application].
    Henry N; Colombier P; Lescaudron L; Hamel O; Le Bideau J; Guicheux J; Clouet J
    Med Sci (Paris); 2014 Dec; 30(12):1091-100. PubMed ID: 25537039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local Delivery of Senolytic Drug Inhibits Intervertebral Disc Degeneration and Restores Intervertebral Disc Structure.
    Lim S; An SB; Jung M; Joshi HP; Kumar H; Kim C; Song SY; Lee JR; Kang M; Han I; Kim BS
    Adv Healthc Mater; 2022 Jan; 11(2):e2101483. PubMed ID: 34699690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell therapy for the degenerating intervertebral disc.
    Tong W; Lu Z; Qin L; Mauck RL; Smith HE; Smith LJ; Malhotra NR; Heyworth MF; Caldera F; Enomoto-Iwamoto M; Zhang Y
    Transl Res; 2017 Mar; 181():49-58. PubMed ID: 27986604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intervertebral disc degeneration in the dog. Part 1: Anatomy and physiology of the intervertebral disc and characteristics of intervertebral disc degeneration.
    Bergknut N; Smolders LA; Grinwis GC; Hagman R; Lagerstedt AS; Hazewinkel HA; Tryfonidou MA; Meij BP
    Vet J; 2013 Mar; 195(3):282-91. PubMed ID: 23177522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimuli-Responsive Delivery Systems for Intervertebral Disc Degeneration.
    Tang J; Luo Y; Wang Q; Wu J; Wei Y
    Int J Nanomedicine; 2024; 19():4735-4757. PubMed ID: 38813390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lessons learned from intervertebral disc pathophysiology to guide rational design of sequential delivery systems for therapeutic biological factors.
    Frapin L; Clouet J; Delplace V; Fusellier M; Guicheux J; Le Visage C
    Adv Drug Deliv Rev; 2019; 149-150():49-71. PubMed ID: 31445063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.